PODOCYTURIA AS A MARKER FOR PREECLAMPSIA

Abstract

The role of kidneys in the pathogenesis of preeclampsia is still a matter of debate. There is strong evidence that a disturbance in the function of normal kidney due to the loss of podocytes is the main cause of the development of proteinuria and hypertension. The release of podocytes, podocytic proteins and podocytic matrix ribonucleic acid (mRNA) can both be used for the diagnostics of preeclampsia and serve as a marker of the active disease of the kidney. The performed in this review analysis of publications showed that podocytes and podocytic proteins can be detected long before the appearance of proteinuria and hypertension, which makes them promising markers for the early diagnosis of preeclampsia. Measurement of the concentration of nephrin and its mRNA allows both assess the risk of development of preeclampsia and make the differential diagnosis between preeclampsia and gestational hypertension with a sufficiently high efficiency already in the second trimester of pregnancy, long before the appearance of the main signs of the disease.

Keywords

preeclampsia / podocyturia / Nephrinuria / diagnostics

References

[1] Шувалова М.П., Фролова О.Г., Ратушняк С.С., Гребенник Т.К., Гусева Е.В. Преэклампсия и эклампсия как причина материнской смертности. Акуш. и гин. 2013; 8: 81-6.

[2] Сидорова И.С., Никитина Н.А. Особенности патогенеза эндотелиоза при преэклампсии. Акуш. и гин. 2015; 1: 72-8.

[3] Raymond D., Peterson E. A critical review of early-onset and late-onset preeclampsia. Obstet. Gynecol. Surv. 2011; 66 (8): 497-506. doi: 10.1097/OGX.0b013e3182331028.

[4] Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am. J. Obstet. Gynecol. 2000; 183 (1): S1-S22.

[5] Hladunewich M.A., Bramham K., Maynard S. Managing glomerular disease in pregnancy. Nephrol. Dial. Transplant. 2017; 32 (Suppl.1): i48-i56. doi: 10.1093/ndt/gfw319.

[6] Smyth A., Ronco C., Garovic V.D. Preeclampsia: a cardiorenal syndrome in pregnancy. Curr. Hypertens. Rep. 2017;19 (2): 15. doi: 10.1007/s11906-017-0714-5.

[7] Roberts J.M. Endothelial dysfunction in preeclampsia. Semin. Reprod. Endocrinol. 1998; 16: 5-15.

[8] Hod T., Cerdeira A.S., Karumanchi S.A. Molecular mechanisms of preeclampsia. Cold Spring Harb. Perspect. Med. 2015; 5 (10). doi: 10.1101/cshperspect.a023473.

[9] Eremina V., Sood M., Haigh J., Nagy A. et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J. Clin. Invest. 2003;111: 707-16.

[10] Furuta I., Zhai T., Ishikawa S., Umazume T. et al. Association between nephrinuria, podocyturia, and proteinuria in women with pre-eclampsia. J. Obstet. Gynaecol. Res. 2017; 43(1): 34-41. doi: 10.1111/jog.13180.

[11] Tianyue Zhai, Itsuko Furuta, Rina Akaishi, Satoshi Ishikawa et al. Alteration of podocyte phenotype in the urine of women with preeclampsia. Sci. Rep. 2016; 6: 24258. doi: 10.1038/srep24258

[12] Konieczny A., Ryba M., Wartacz J., Czyżewska-Buczyńska A. et al. Podocytes in urine, a novel biomarker of preeclampsia? Adv. Clin. Exp. Med. 2013; 22: 145-9.

[13] Trimarchi H. Podocyturia: What is in a name? J. Transl. Int. Med. 2015; 3 (2): 51-6. doi: 10.1515/jtim-2015-0003

[14] Garovic V.D., Wagner S.J., Turner S.T., Rosenthal D.W. et al. Urinary podocyte excretion as a marker for preeclampsia. Am. J. Obstet. Gynecol. 2007; 196 (4): 320 e1-7. doi: 10.1016/j.ajog.2007.02.007

[15] Chen G., Zhang L., Jin X. et al. Effects of angiogenic factors, antagonists, and podocyte injury on development of proteinuria in preeclampsia. Reprod. Sci. 2012; 20 (5): 579-88.

[16] Craici I.M., Wagner S.J., Bailey K.R., Fitz-Gibbon P.D. et al. Podocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective study. Hypertension. 2013; 61 (6): 1289-96. doi: 10.1161 /HYPERTENSIONAHA.

[17] Henao D.E., Saleem M.A. Proteinuria in preeclampsia from a podocyte injury perspective. Curr. Hypertens. Rep. 2013; 15: 600-5. doi: 10.1007/s11906-013-0400-1

[18] White W.M., Garrett A.T., Craici I.M., Wagner S.J., Fitz-Gibbon P.D. et al. Persistent urinary podocyte loss following preeclampsia may reflect subclinical renal injury. PLoS ONE. 2014; 9 (3): e92693. doi: 10.1371

[19] Eremina V., Jefferson J.A., Kowalewska J., Hochster H. et al. VEGF inhibition and renal thrombotic microangiopathy. N. Engl. J. Med. 2008; 358 (11): 1129-36. doi: 10.1056/nejmoa0707330

[20] Wang Y., Zhao S., Loyd S., Groome L.J. Increased urinary excretion of nephrin, podocalyxin, and βig-h3 in women with preeclampsia. Am. J. Physiol. Renal. Physiol. 2012; 302 (9): F1084-9. doi: 10.1152/ajprenal.00597.2011.

[21] Son G.H. , Kwon J.Y., Lee S., Park J. et el. Comparison of serum and urinary nephrin levels between normal pregnancies and severe preeclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 2013; 166 (2): 139-44. doi: 10.1016/j.ejogrb.2012.10.011.

[22] Collino F., Bussolati B., Gerbaudo E. et al. Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells. Am. J. Physiol. Renal. Physiol. 2008; 294: F1185-94.

[23] Kelder T.P., Penning M.E., Uh H.-W., Cohen D. Quantitative polymerase chain reaction-based analysis of podocyturia is a feasible diagnostic tool in preeclampsia. Hypertension. 2012; 60: 1538-44.

[24] Garovic V.D., Wagner S.J., Petrovic L.M., Gray C.E. et al. Glomerular expression of nephrin and synaptopodin, but not podocin, is decreased in kidney sections from women with preeclampsia. Nephrol. Dial. Transplant. 2007; 22 (4): 1136-43.

[25] Jim B., Mehta S., Qipo A., Kim K., Cohen H.W. et al. A comparison of podocyturia, albuminuria and nephrinuria in predicting the development of preeclampsia: a prospective study. PLoS One. 2014; 9 (7): e101445. doi: 10.1371/journal.pone.0101445. eCollection 2014.

RIGHTS & PERMISSIONS

Eco-Vector